Amicus Therapeutics’ first oral drug for the rare condition Fabry disease has been approved by the FDA, giving patients an alternative to conventional injected enzyme replacement therapy. Galafold ...

Get the detailed quarterly/annual income statement for Amicus Therapeutics, Inc. (FOLD). Find out the revenue, expenses and profit or loss over the last fiscal year.

The 2026 Design and Verification Conference and Exhibition (DVCon U.S.) has unveiled its keynote speakers and an array of tutorials and workshops, highlighting advancements in AI-driven technologies ...

BETHLEHEM, Pa. -- A New York-based investment group that leases housing to students has acquired dozens of South Bethlehem properties near Lehigh University. Northampton County records show 46 ...

Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...

Amicus™ high collection efficiency yields multiple products per donor for the lowest-cost platelet production. It is designed to adapt to the requirements of different collection settings. Let our ...